Nova SBE Pegs Portugal's Farmácia Network at 1.12% of GDP and 53,000 Sustained Jobs — €3.23 Billion Annual Footprint Underwrites the ANF Negotiation With the SNS

A Nova SBE economic-impact study commissioned by the Associação Nacional das Farmácias (ANF) pegs Portugal's community-pharmacy network at 1.12% of GDP, 53,000 sustained jobs and a €3.23 billion annual economic footprint, ECO reported on Friday 29 May. The reading — which combines the direct, indirect and induced impact channels — lands on the negotiation table with the Ministério da Saúde and the SNS over the post-2026 pharmacy-services pact and the role of community pharmacies in the SNS clinical referral pathway.

The Headline Numbers

The study's three load-bearing figures are: 1.12% of Portuguese GDP — the total value-added contribution across direct (pharmacy operations), indirect (suppliers, wholesalers, the GDP contribution of pharmacy-purchased inputs) and induced (employee spending, household-income multiplier) channels; 53,000 jobs sustained across the same three impact channels, with direct employment concentrated in the roughly 2,900-3,000 community pharmacies operating across the Portuguese network; and €3.23 billion in annual economic activity attributable to the pharmacy network, with the bulk concentrated in the SNS-reimbursed medicines distribution channel plus the cash-pay over-the-counter, parapharmacy and pharmacy-services books.

The Methodology Frame

Nova SBE's economic-impact studies — including the high-profile 2024 Sonae study that pegged the retail-and-services group at 3.7% of GDP and 259,000 jobs — use input-output multiplier methodology calibrated against the INE national accounts table. The pharmacy reading sits inside the same methodological frame: the 1.12% GDP figure is the value-added contribution rather than the gross sales figure, which removes the double-counting that would inflate the headline if pharmacy revenue and the supplier-chain revenue were both included unadjusted. The 53,000-job count is the sum of full-time-equivalent (FTE) positions across the three channels rather than a headcount of distinct individuals.

The Negotiation Context

The ANF commissioned the Nova SBE work as the leading study underpinning its negotiation posture with the Ministério da Saúde on the 2026-2030 community-pharmacy services pact — the regulatory framework that sets pharmacy reimbursement rates on SNS medicines, the role of pharmacies in administering vaccines, in the new clinical-referral pilots, and in the Receita Sem Papel digital prescription network. The study lands in parallel with the OMV — the Ordem dos Médicos Veterinários — petition on the IVA reduction for veterinary services, both signalling a sustained sector-association mobilisation around the post-OE 2026 negotiation window.

What This Means for Portugal — The Bottom Line

• The community-pharmacy network is a larger economic footprint than the pharmaceutical-distribution chain. Distribuição farmacêutica — the wholesale layer — contributed roughly €302 million directly to the 2024 Portuguese economy on the Logifarma-Cooprofar-Plural-OCP tape; community pharmacies, by Nova SBE's reading, contribute roughly ten times that figure when the full multiplier is taken in.
• The job count is geographically distributed. Unlike the high-concentration retail tape that dominates the Sonae and Jerónimo Martins economic-impact studies, the community-pharmacy network has at least one operator in essentially every concelho — the 53,000 jobs are distributed across the full territorial perimeter, with pharmacies often the only formally trained health-services point in interior and rural concelhos.
• The negotiation leverage is now numerical. The ANF can take a 1.12%-of-GDP figure into the Ministério da Saúde's negotiation room as the headline-grabbing piece; the previous round of pharmacy negotiations relied on less consolidated impact analysis and the political weight that comes with national-coverage anchoring.
• The post-2026 pharmacy-services pilot is the load-bearing variable. The Ministério da Saúde and the ANF have an open file on the expanded role of community pharmacies in the SNS clinical pathway — including medication review, chronic-disease monitoring and selected vaccination programmes; the Nova SBE study reads as the supporting case for fee uplift on the expanded services tape.

The full Nova SBE report is published on the ANF website at anf.pt; the Ministério da Saúde has not yet commented publicly on the figures.